Skip to main content

Legend Capital — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

214
Companies
$4.6B
Total invested
$30.6M
Avg. check
36
Industries
Artificial Intelligence (AI) 9Medical 8Health Care 6Biotechnology 6Pharmaceutical 3Biopharma 3+30 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 214
Axonics Modulation Technologies
August 2022

Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.

Health Diagnostics · Irvine$111.7M Post-IPO Equity
Pony.ai
August 2025

Pony.ai develops autonomous driving technology for vehicles that operates using artificial intelligence and machine learning.

Artificial Intelligence (AI) · Fremont$12.9M Corporate Round
BioMap
June 2024

BioMap is a pioneer in life science AI Foundation Models

Artificial Intelligence (AI) · Palo AltoVenture - Series Unknown
Nanochap
May 2026

Nanochap is an intelligent medical hardware developer.

Hardware · Melbourne$44.0M Venture - Series Unknown
VectorBuilder
May 2023

VectorBuilder is an online platform for vector cloning and other CRO services.

Biotechnology · ChicagoVenture - Series Unknown
Spacety
April 2026

Spacety is a commercial microsatellite start-up that offers science and technology validation experiments for spacecrafts.

Aerospace · Esch-sur-alzetteVenture - Series Unknown
Xellar Biosystems
April 2026

Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

Artificial Intelligence (AI) · Newton$50.0M Series A
Angitia Biopharmaceuticals
February 2026

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Biopharma · Westlake Village$130.0M Series D
VITURE
February 2026

VITURE is a 2C technology company dedicated to developing AR technology, creating trendy XR glasses.

3D Technology · San Francisco$100.0M Venture - Series Unknown
Healing Paper
February 2025

Healing Paper uses ICT to improve medical service access, reduce costs, and balance information between experts and non-experts.

Beauty · Seocho$29.7M Series C
Saige Research
September 2023

Saige Research specializes in artificial intelligence solutions for industrial inspection and quality control.

Artificial Intelligence (AI) · Seoul$11.6M Series B
N1 Life
April 2023

A biotech comany advancing tissue-selective drug delivery platform technologies to revolutionize drug development.

Biotechnology · Milpitas$10.0M Seed
Sanegene Bio
December 2025

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

Biopharma · Woburn$110.0M Series B
Obita
December 2025

Obita is a B2B financial network that offers stablecoin-driven transactions for enterprises, merchants, and fintechs.

Information Services · Hong KongSeed
Rxilient
October 2023

Rxilient provides pharmaceutical CDMO services.

Medical · Singapore$30.0M Venture - Series Unknown
Zhijian Power
March 2026

Zhijian Power is a high-tech enterprise specializing in the research and development of intelligent driving technology.

Artificial Intelligence (AI) · HangzhouSeries Unknown
Manifold AI
March 2026

Manifold AI is an artificial intelligence company that provides development of embodied intelligent world models.

Artificial Intelligence (AI) · Chaoyang$28.9M Seed
X Square
February 2026

X Square is a company aiming to create a universal brain-cerebellum system for robots, encompassing capabilities from perception to action.

Artificial Intelligence (AI) · ShenzhenSeries A
GluBio Therapeutics
February 2026

GluBio Therapeutics engages in molecular glue-targeted protein degradation drug discovery.

Biotechnology · Hangzhou$30.0M Corporate Round
Zhiran Medical
February 2026

Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders.

Health Care · Beijing$43.4M Series A
Huixin Bio
February 2026

Huixin Bio is a developer of exosome purification products and early cancer detection technology.

Biopharma · Shenzhen$14.4M Series A
Neolix
February 2026

Neolix is a technology company that designs, manufactures, and operates low-cost autonomous delivery vehicles.

Artificial Intelligence (AI) · BeijingSeries Unknown
RobotMeta
February 2026

An AI & Robotics Company based in Shenzhen,China.

Artificial Intelligence (AI) · Shenzhen$14.4M Series B
Guoke Ion
February 2026

Guoke Ion is an innovative enterprise focusing on the integration of advanced medical technology and financial services.

Haidian$115.2M Series A

Where Legend Capital invests

Artificial Intelligence (AI)9
Medical8
Health Care6
Biotechnology6
Pharmaceutical3
Biopharma3

About Legend Capital's portfolio

How many companies has Legend Capital invested in?

Legend Capital has invested in 214 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Legend Capital invest in?

Legend Capital's top investment sectors include Artificial Intelligence (AI), Medical, Health Care, Biotechnology, Pharmaceutical. The firm invests across 36 different industry categories.

What is Legend Capital's largest investment?

Among tracked funding rounds, Angitia Biopharmaceuticals received $130.0M in a Series D round. Legend Capital's total known invested capital is $4.6B.

What is the average investment size for Legend Capital?

Legend Capital's average investment size is $30.6M across its portfolio of 214 companies.

What are Legend Capital's most recent investments?

Recent Legend Capital portfolio additions include Axonics Modulation Technologies, Pony.ai, BioMap, Nanochap, VectorBuilder. These companies were founded in 2020 or later.

Reach the founders behind these 214 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →